Inhibitory effects of novel 3(2H)pyridazinone-triazole derivatives against acetylcholinesterase enzyme
Özet
Alzheimer's disease is a neurological disease characterized by the destruction of brain cells. In this disease, which causes a decrease in thought, memory and behavioral functions, the symptoms appear gradually with age. In this study, inhibition of acetylcholinesterase enzyme which is an important target in accordance with the cholinergic hypothesis, was studied. New 3(2H)pyridazinone-triazole derivatives were synthesized, confirmed by1H-NMR,13C-NMR, HRMS analysis and their IC50 and Ki values were studied. The inhibition constants (Ki) of the compounds against the AChE enzyme ranged from 2.35 ± 0.18 to 5.15 ± 0.46 µM. The compound with the best inhibitory properties was compound 6d with a Ki value of 2.35 ± 0.18 µM. In addition, to support the experimental data, molecular docking studies were carried out with 6b, 6d, 6e and 6f compounds with AChE crystal structure (PDB ID:4M0E). © 2022 Marmara University Press.
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Bozbey, İrem | |
| dc.contributor.author | Önel, Gülce Taşkor | |
| dc.contributor.author | Türkmenoğlu, Burçin | |
| dc.contributor.author | Gürsoy, Şule | |
| dc.contributor.author | Dilek, Esra | |
| dc.contributor.author | Ergün, Muhammed | |
| dc.contributor.author | Özçelik, Azime Berna | |
| dc.contributor.author | Uysal, Mehtap | |
| dc.date.accessioned | 2026-10-18T20:27:30.502010463Z | |
| dc.date.available | 2026-10-18T20:27:30.502010463Z | |
| dc.date.issued | 2022 | |
| dc.description.abstract | Alzheimer's disease is a neurological disease characterized by the destruction of brain cells. In this disease, which causes a decrease in thought, memory and behavioral functions, the symptoms appear gradually with age. In this study, inhibition of acetylcholinesterase enzyme which is an important target in accordance with the cholinergic hypothesis, was studied. New 3(2H)pyridazinone-triazole derivatives were synthesized, confirmed by1H-NMR,13C-NMR, HRMS analysis and their IC50 and Ki values were studied. The inhibition constants (Ki) of the compounds against the AChE enzyme ranged from 2.35 ± 0.18 to 5.15 ± 0.46 µM. The compound with the best inhibitory properties was compound 6d with a Ki value of 2.35 ± 0.18 µM. In addition, to support the experimental data, molecular docking studies were carried out with 6b, 6d, 6e and 6f compounds with AChE crystal structure (PDB ID:4M0E). © 2022 Marmara University Press. | |
| dc.description.sponsorship | Funding text 1: Acknowledgements: We thank Erzincan Binali Yıldırım University (Project Number: TSA-2020-664) for their financial support. The authors would like to thank Erzincan Binali Yıldırım University, Basic Sciences Application and Research Center (EBYU-EUTAM) for the Schrödinger Maestro 2021-2 program.; Funding text 2: We thank Erzincan Binali Yıldırım University (Project Number: TSA-2020-664) for their financial support. The authors would like to thank Erzincan Binali Yıldırım University, Basic Sciences Application and Research Center (EBYU-EUTAM) for the Schrödinger Maestro 2021-2 program. | |
| dc.identifier.doi | 10.29228/jrp.239 | |
| dc.identifier.eissn | 2630-6344 | |
| dc.identifier.endpage | 1471 | |
| dc.identifier.issn | 2630-6344 | |
| dc.identifier.issue | 5 | |
| dc.identifier.scopus | 2-s2.0-85137920793 | |
| dc.identifier.startpage | 1461 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/12627 | |
| dc.identifier.volume | 26 | |
| dc.identifier.wos | WOS:000929825400035 | |
| dc.language.iso | en | |
| dc.publisher | Marmara University | |
| dc.relation.ispartof | Journal of Research in Pharmacy | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Acetylcholinesterase | |
| dc.subject | alzheimer’s disease | |
| dc.subject | molecular docking | |
| dc.subject | pyridazinone | |
| dc.subject | triazole | |
| dc.subject | 2 [[4 (3 bromophenyl) 5 thioxo 4,5 dihydro 1h 1,2,4 triazol 3 yl]methyl] 6 [4 (4 chlorophenyl)piperazin 1 yl]pyridazin 3(2h) one | |
| dc.subject | 2 [[4 (4 bromophenyl) 5 thioxo 4,5 dihydro 1h 1,2,4 triazol 3 yl]methyl] 6 [4 (4 chlorophenyl)piperazin 1 yl]pyridazin 3(2h) one | |
| dc.subject | 3(2h)pyridazinone triazole | |
| dc.subject | 6 [4 (4 chlorophenyl)piperazin 1 yl] 2 [(4 phenyl 6 thioxo 4,5 dihydro 1h 1,2,4 triazol 3 yl)methyl]pyridazin] 3(2h) one | |
| dc.subject | 6 [4 (4 chlorophenyl)piperazin 1 yl] 2 [[4 (2 methoxyphenyl)-5-thioxo-4,5-dihydro 1h 1,2,4 triazol 3 yl]methyl]pyridazin 3(2h) one | |
| dc.subject | 6 [4 (4 chlorophenyl)piperazin 1 yl] 2 [[4 (3 methoxyphenyl)-5-thioxo-4,5-dihydro 1h 1,2,4 triazol 3 yl]methyl]pyridazin 3(2h) one | |
| dc.subject | 6 [4 (4 chlorophenyl)piperazin 1 yl] 2 [[5 thioxo 4 [4 (trifluoromethoxy)phenyl] 4,5 dihydro 1h 1,2,4 triazol 3 yl]methyl]pyridazin 3(2h) one | |
| dc.subject | cholinesterase inhibitor | |
| dc.subject | tacrine | |
| dc.subject | triazole derivative | |
| dc.subject | unclassified drug | |
| dc.subject | Article | |
| dc.subject | carbon nuclear magnetic resonance | |
| dc.subject | crystal structure | |
| dc.subject | enzyme inhibition | |
| dc.subject | IC50 | |
| dc.subject | inhibition constant | |
| dc.subject | mass spectrometry | |
| dc.subject | proton nuclear magnetic resonance | |
| dc.title | Inhibitory effects of novel 3(2H)pyridazinone-triazole derivatives against acetylcholinesterase enzyme | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.scopus | 4 | |
| rdl.citation.trdizin | 0 | |
| rdl.citation.wos | 2 | |
| rdl.department | ERZİNCAN BİNALİ YILDIRIM ÜNİVERSİTESİ | |
| rdl.department | SİVAS CUMHURİYET ÜNİVERSİTESİ | |
| rdl.department | GAZİ ÜNİVERSİTESİ | |
| rdl.oa.status | gold | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.source.index | TRDIZIN | |
| rdl.wos.index | Emerging Sources Citation Index (ESCI) |
